Duan Xiaojuan, Zhou Yibing, Dai Hongya, Zhao Lirong, Qian Jindong, Yang Dingqiang, Zhang Liwei, Luo Can, Li Guanghui
Institute of Cancer Research, Xinqiao Hospital, ARMY Medical University, Chongqing, China.
J Appl Clin Med Phys. 2020 Aug;21(8):35-46. doi: 10.1002/acm2.12909. Epub 2020 Jun 3.
To investigate the daily setup, interfraction motion, variability in the junction areas, and dosimetric effect in craniospinal irradiation (CSI) patients.
Fifteen CSI patients who had undergone split-field IMRT were followed in the study. Previous, middle, and posttreatment, each target volume position was evaluated using the ExacTrac system. Interfraction and intrafraction motions, the margin of the junction in adjacent targets volumes, and the dosimetric effect of the longitudinal residual error were analyzed.
The lowest attainment rate within the tolerance of the initial setup error was 66.79% in six directions. The values of the initial error were within 15 mm (SD 4.5 mm) in the translation direction and 5° (SD 1.3°) in the rotation direction after the transposition of the treatment isocenter. With the guidance of the ExacTrac system, the interfraction and intrafraction residual errors were almost within the tolerance after correction, the margin of CTV-to-PCTV was in the range of target expansion criteria. The residual longitudinal errors resulted in only slight changes in the mean doses of PGTV and PCTV, while the maximum dose of the spinal cord increased by 16.1%. The patients did not exhibit any side-effects by the overall treatment during the follow-up period.
Position correction is necessary after setup and the transposition of the treatment isocenter. Intra-fraction motion in the lateral direction should be monitored throughout treatment. The position errors in junction areas are almost within the tolerance after correction. The patients did not exhibit any side-effects by the overall treatment.
研究全脑全脊髓照射(CSI)患者的每日摆位、分次间运动、交界区的变异性以及剂量学效应。
本研究纳入了15例行分野调强放疗的CSI患者。在治疗前、治疗中期和治疗后,使用ExacTrac系统评估每个靶区体积的位置。分析分次间和分次内运动、相邻靶区体积交界处的边界以及纵向残余误差的剂量学效应。
初始摆位误差在六个方向上的最低达标率为66.79%。治疗等中心移位后,初始误差在平移方向上为15毫米以内(标准差4.5毫米),在旋转方向上为5°以内(标准差1.3°)。在ExacTrac系统的引导下,分次间和分次内残余误差在纠正后几乎都在允许范围内,临床靶区(CTV)到计划靶区(PTV)的边界在靶区外放标准范围内。纵向残余误差仅导致计划靶区(PGTV)和PTV的平均剂量有轻微变化,而脊髓的最大剂量增加了16.1%。在随访期间,患者未因整体治疗出现任何副作用。
在摆位和治疗等中心移位后需要进行位置校正。在整个治疗过程中应监测侧向的分次内运动。交界区的位置误差在纠正后几乎都在允许范围内。患者未因整体治疗出现任何副作用。